CTSLP8: A Protein Interaction and Potential Drug Target for Cancer

Target Name: CTSLP8

NCBI ID: G1518

Other Name(s): CTSL1P8 | Cathepsin L pseudogene 8 | cathepsin L pseudogene 8

CTSLP8: A Protein Interaction and Potential Drug Target for Cancer

CTSLP8 (CTSL1P8) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is costilabinin-conjugated transmembrane protein 8, and it is also known as CTSLP8-containing protein or CTP8.

CTSLP8 is a member of the CTP family, which includes proteins that are involved in various cellular processes, including cell signaling, DNA replication, and protein transport. The CTSLP8 protein is approximately 110 amino acids long and has a calculated molecular weight of 18.1 kDa.

One of the unique features of CTSLP8 is its ability to interact with other proteins and molecules. It has been shown to interact with a variety of protein partners, including the protein known as ALX148, which is a known drug target for cancer.

ALX148 is a small protein that is expressed in various tissues of the body, including the brain. It has been shown to play a role in cell signaling and is a potential drug target for cancer.

Research has also suggested that CTSLP8 may be involved in the regulation of various cellular processes, including cell growth, apoptosis (programmed cell death), and inflammation.

One potential mechanism by which CTSLP8 may be involved in these processes is through its ability to interact with ALX148. This interaction may be involved in the regulation of ALX148 activity and could potentially make it a useful drug target for cancer.

In addition to its potential role in drug targeting, CTSLP8 has also been shown to have potential as a biomarker for various diseases. For example, it has been shown to be expressed in the brains of individuals with Alzheimer's disease, a condition that is characterized by the progressive loss of brain cells.

Additionally, CTSLP8 has been shown to be expressed in the hearts of individuals with heart failure, a condition that is characterized by the progressive loss of heart muscle. This suggests that CTSLP8 may be a useful biomarker for heart failure.

In conclusion, CTSLP8 is a protein that has been shown to interact with various proteins and molecules and has potential as a drug target for cancer. Its potential as a biomarker for various diseases makes it an interesting target for further research. Further studies are needed to fully understand the role of CTSLP8 in cellular processes and its potential as a drug or biomarker.

Protein Name: Cathepsin L Pseudogene 8

More Common Targets